Objective: The objective of the study was to describe the process of implementing a
technology system to improve safety and quality in all the processes involved in the treatment with
parenteral antineoplastic agents within an interdisciplinary team and to analyze the errors detected and
avoided by this system.
Materials and Methods: This is an observational and retrospective study, where the implementation of
an expert technology system in all phases of the therapeutic process is described, including:
prescription, validation, preparation and administration of drugs. This system integrates a qualitative
and quantitative control (with an optical codes reader and a gravimetric method). All the
administration process was also observed and controlled.
A descriptive analysis of the errors recorded in the various stages of the process was carried out
during 3 months.
Results: There were a total of 2185 drugs prescribed and prepared, belonging to 382 patients. 14
prescription errors were recorded, representing 0.6% of admixtures. All were potential errors that the
system helped to avoid and did not reach the patient.
Qualitative control results: a total of 93(4.2%) incorrect code readings were detected and 16(0.7%)
readings for wrong components / wrong drugs. Explaining the results of quantitative control, 95
mixtures (4.3%) were prepared incorrectly -29(1.3%) due to an overdosage, and 66(3.0%) because of
Conclusion: A new support technology was introduced to increase pharmacotherapeutic security in
oncohematology, which successfully achieved the purpose in all stages of the process.
In the study period, the implemented system successfully intercepted all the errors that could have
reached the patient in 6.2% of the prescribed mixtures.